Renal cancer patients join a Dutch research kidney study
Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study enrolls people newly diagnosed with kidney cancer (including when it has spread) to help build research resources for future kidney cancer care. If you qualify, your information may be used to better understand outcomes and improve treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have newly diagnosed kidney cancer (renal cell carcinoma), including cases where it already spread
- You may also qualify if you have kidney cancer with metastases that appeared at the same time or later
- You can understand Dutch language
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at patients with kidney cancer that hasn't spread and is considered high-risk. It uses a registry to learn more about these patients to improve future care.
This study looks at what makes people with kidney cancer decide to join clinical trials. By participating, you'll help researchers understand how to make future studies easier for patients to access and complete.
This trial studies whether removing the primary kidney tumor (cytoreductive nephrectomy) in addition to standard immunotherapy treatment can help people with metastatic kidney cancer. It is for patients whose cancer has not gotten worse after 6 months of initial treatment.
This trial tests a new drug, PF-08634404, alone or with other cancer treatments, for adults with advanced kidney cancer that has not been treated before. It aims to see if the drug can help shrink tumors or stop them from growing.
This trial tests a new PET scan (a special imaging test) to better grade kidney cancer before surgery. The goal is to see if this scan can help doctors understand how aggressive the cancer is, so they can plan the best treatment for you.
This study follows people with kidney cancer who are scheduled for surgery to remove their tumor. It aims to learn more about the disease and how it behaves over time.
Hear when a new Renal Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.